Literature DB >> 11036285

Early colorectal cancer with special reference to the superficial nonpolypoid type from a histopathologic point of view.

Y Ajioka1, H Watanabe, S Kazama, H Hashidate, J Yokoyama, S Yamada, H Takaku, K Nishikura.   

Abstract

The incidence and histopathologic characteristics of nonpolypoid (superficial type) early colorectal carcinomas were studied and compared with those of the polypoid type. The superficial type was subclassified as elevated (type IIa), type IIa with central depression (type IIa + IIc), plain (type IIb), depressed (type IIc), and IIc with marginal elevation (type IIc + IIa). The superficial type comprised 22% and 27% of intramucosal and submucosal carcinomas, respectively. Pure type IIb was not found, and there were only three pure type IIc lesions. Type IIa + IIc and IIc + IIa (and IIc) showed a significantly higher rate of submucosal invasion among the small tumors (59% and 71% less than 20 mm, respectively) compared to the polypoid type; type IIa showed no significant difference. The incidence of lymph node metastasis among submucosal carcinomas showed no significant difference between the superficial type and the polypoid type. About 64% and 52% of type IIa and IIa + IIc tumors accompanied residual adenoma, suggesting that they originated from small, flat adenomas through the adenoma-carcinoma sequence, whereas type IIc + IIa (and IIc) did not have an adenomatous component, implying that they arose de novo or originated through an adenoma-carcinoma sequence at a smaller size than the type IIa and IIa + IIc lesions. Superficial-type early colorectal carcinomas are not rare, and they are not uniform in nature. Rapid growth and invasion to the submucosa is characteristic of superficial-type lesions with a central depression, and only superficial depressed (type IIc + IIa, IIc) lesions can arise de novo. Although they grow rapidly to invade the submucosa, it cannot be said that they show more aggressive behavior than the polypoid type.

Entities:  

Mesh:

Year:  2000        PMID: 11036285     DOI: 10.1007/s002680010150

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  7 in total

1.  Surveillance colonoscopy in ulcerative colitis: magnifying chromoendoscopy in the spotlight.

Authors:  R Kiesslich; M F Neurath
Journal:  Gut       Date:  2004-02       Impact factor: 23.059

Review 2.  Endoscopic mucosal resection: an evolving therapeutic strategy for non-polypoid colorectal neoplasia.

Authors:  R Kiesslich; M F Neurath
Journal:  Gut       Date:  2004-09       Impact factor: 23.059

3.  Histopathological and genetic differences between polypoid and non-polypoid submucosal colorectal carcinoma.

Authors:  Ichiro Hirata; Fang-Yu Wang; Mitsuyuki Murano; Takuya Inoue; Ken Toshina; Takashi Nishikawa; Kentaro Maemura
Journal:  World J Gastroenterol       Date:  2007-04-14       Impact factor: 5.742

4.  Establishment and characterization of a new cell line derived from human colorectal laterally spreading tumor.

Authors:  Xin-Ying Wang; Zhou-Sheng Lai; Chung-Man Yeung; Ji-De Wang; Wen Deng; Hoi-Yee Li; Yu-Jing Han; Hsiang-Fu Kung; Bo Jiang; Marie Chia-mi Lin
Journal:  World J Gastroenterol       Date:  2008-02-28       Impact factor: 5.742

Review 5.  Annex to Quirke et al. Quality assurance in pathology in colorectal cancer screening and diagnosis: annotations of colorectal lesions.

Authors:  Michael Vieth; Phil Quirke; René Lambert; Lawrence von Karsa; Mauro Risio
Journal:  Virchows Arch       Date:  2011-01       Impact factor: 4.064

6.  The risk of lymph node metastasis makes it unsafe to expand the conventional indications for endoscopic treatment of T1 colorectal cancer: A retrospective study of 428 patients.

Authors:  Bun Kim; Eun Hye Kim; Soo Jung Park; Jae Hee Cheon; Tae Il Kim; Won Ho Kim; Hoguen Kim; Sung Pil Hong
Journal:  Medicine (Baltimore)       Date:  2016-09       Impact factor: 1.889

7.  FICE in Predicting Colorectal Flat Lesion Histology.

Authors:  Cevher Akarsu; Nuri A Sahbaz; Ahmet C Dural; Osman Kones; Sinan Binboga; Hamit A Kabuli; Alpen Y Gumusoglu; Halil Alis
Journal:  JSLS       Date:  2017 Oct-Dec       Impact factor: 2.172

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.